Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate cardiac safety of brentuximab vedotin (SGN-35) in patients with CD30-positive cancers. The study will assess electrical activity of the heart before and after ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Seagen Inc.
Collaborators
NCT06510361 · Lymphoma, Follicular Lymphoma, and more
NCT05442515 · B-NHL, B-Non Hodgkin Lymphoma, and more
NCT07162181 · Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, and more
NCT06528301 · Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL), and more
NCT05824585 · Lymphoma, Non-Hodgkin
University of Alabama at Birmingham
Birmingham, Alabama
City of Hope National Medical Center
Duarte, California
Stanford Cancer Center
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions